Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.

Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A, Ford D, ODYSSEY Trial Team

Open source

DOI: 10.1016/s2352-3018(22)00163-1
Published: 2022 Sep
Container: The lancet. HIV
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-22-00163-1,
  title = {Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.},
  author = {Amuge P and Lugemwa A and Wynne B and Mujuru HA and Violari A and Kityo CM and Archary M and Variava E and White E and Turner RM and Shakeshaft C and Ali S and Nathoo KJ and Atwine L and Liberty A and Bbuye D and Kaudha E and Mngqibisa R and Mosala M and Mumbiro V and Nanduudu A and Ankunda R and Maseko L and Kekitiinwa AR and Giaquinto C and Rojo P and Gibb DM and Turkova A and Ford D and ODYSSEY Trial Team},
  year = {2022},
  journal = {The lancet. HIV},
  doi = {10.1016/s2352-3018(22)00163-1},
  url = {https://doi.org/10.1016/s2352-3018(22)00163-1}
}

RIS

TY  - JOUR
TI  - Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
AU  - Amuge P
AU  - Lugemwa A
AU  - Wynne B
AU  - Mujuru HA
AU  - Violari A
AU  - Kityo CM
AU  - Archary M
AU  - Variava E
AU  - White E
AU  - Turner RM
AU  - Shakeshaft C
AU  - Ali S
AU  - Nathoo KJ
AU  - Atwine L
AU  - Liberty A
AU  - Bbuye D
AU  - Kaudha E
AU  - Mngqibisa R
AU  - Mosala M
AU  - Mumbiro V
AU  - Nanduudu A
AU  - Ankunda R
AU  - Maseko L
AU  - Kekitiinwa AR
AU  - Giaquinto C
AU  - Rojo P
AU  - Gibb DM
AU  - Turkova A
AU  - Ford D
AU  - ODYSSEY Trial Team
PY  - 2022
JO  - The lancet. HIV
DO  - 10.1016/s2352-3018(22)00163-1
UR  - https://doi.org/10.1016/s2352-3018(22)00163-1
ER  -

APA

P, A., A, L., B, W., HA, M., A, V., CM, K., M, A., E, V., E, W., RM, T., C, S., S, A., KJ, N., L, A., A, L., D, B., E, K., R, M., M, M., V, M., A, N., R, A., L, M., AR, K., C, G., P, R., DM, G., A, T., D, F., & Team, O. T. (2022). Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(22)00163-1

Source records

pubmed · retrieved 2026-09-26T05:15:27.737Z